Clark & Stuart Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$785K Buy
9,027
+1,000
+12% +$88.1K 0.48% 33
2026
Q2
$634K Buy
8,027
+1,700
+27% +$137K 0.4% 37
2026
Q1
$553K Buy
6,327
+500
+9% +$47.9K 0.37% 36
2025
Q4
$564K Sell
5,827
-500
-8% -$48.6K 0.39% 35
2025
Q3
$607K Hold
6,327
– – 0.43% 34
2025
Q2
$556K Hold
6,327
– – 0.42% 33
2025
Q1
$573K Hold
6,327
– – 0.42% 32
2024
Q4
$509K Buy
+6,327
New +$548K 0.37% 33

Other funds holding MDT

Clark & Stuart Inc's MDT Position: Q3 2026 in Review

Clark & Stuart Inc increased its Medtronic (MDT) stake by 12% in Q3 2026, buying an estimated $88.1K and bringing the position to 9,027 shares worth $785K. The position accounts for 0.48% of the portfolio, ranked #33.

Clark & Stuart Inc first reported a position in MDT in Q4 2024 and has held it in 8 quarters since. 529 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Clark & Stuart Inc held 9,027 shares of Medtronic worth $785K as of Q3 2026.
  • Clark & Stuart Inc bought 1,000 Medtronic shares in Q3 2026, an estimated $88.1K.
  • Medtronic made up 0.48% of Clark & Stuart Inc's portfolio in Q3 2026, its #33 holding.
  • Clark & Stuart Inc first reported a position in Medtronic in Q4 2024 and has held it in 8 quarters since.
  • 529 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Clark & Stuart Inc's 13F filing for Q3 2026, filed 14 Oct 2026.